Living The Lie
Central planners face an impossible task. They must compel people to behave in ways that go contrary to freedom of choice. Only those full of…
The 5 Best Defense Stocks To Buy (With Dividends) For February 2023
War is good business. The U.S. is very good at running defense companies. When government funding lags, defense contractors merge around the latest technologies. When…
3 Stocks To Buy When Your Tax Refund Check Arrives
Whether you’re due a tax refund or not, putting your money to work is important. Indeed, one of the best ways to do that is…
1 “Strong Bullish” Stock + 2 Mega Trends = A Potent Combo For 2023
Sometimes the best road to stock gains is to find companies that are involved in multiple mega trends. We’re no stranger to energy’s bullish run…
Are You Ready For When Opportunity Knocks? Sprott PM Projections
Chris sits down with Craig Hemke of Sprott Money to talk about current opportunities and where the market may go next through the lens of…
The 7 Most Promising Psychedelic Stocks To Buy In February
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now investigating their potential therapeutic…
The 3 Most Undervalued Renewable Energy Stocks for Your February Buy List
Renewable energy stocks have been in a downturn since early 2021. However, the iShares Global Clean Energy ETF (NASDAQ:ICLN) outperformed the broader market in 2022,…
The Forever Battery That Promises To Change The EV Industry
The EV Revolution is in full-swing right now. After more than tripling in 2021, global electric vehicle sales rose over 60% in the first six…
7 CRISPR Stocks With The Best Long-Term Potential
CRISPR technology has the potential to revolutionize the way we approach medicine. This technology has already been used in a variety of applications, including gene…
3 Pharma Stocks That Will Mint Millionaires
In recent weeks, the Street has become much more enamored with pharma stocks than it was previously. The iShares Biotechnology ETF (NASDAQ:IBB) climbed 6% so…